Henry Schein (HSIC) : Putnam Fl Investment Management Co reduced its stake in Henry Schein by 0.82% during the most recent quarter end. The investment management company now holds a total of 20,908 shares of Henry Schein which is valued at $3,756,749 after selling 172 shares in Henry Schein , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Henry Schein makes up approximately 0.43% of Putnam Fl Investment Management Co’s portfolio.
Other Hedge Funds, Including , California State Teachers Retirement System reduced its stake in HSIC by selling 4,371 shares or 2.46% in the most recent quarter. The Hedge Fund company now holds 173,277 shares of HSIC which is valued at $31,134,411. Henry Schein makes up approx 0.06% of California State Teachers Retirement System’s portfolio.Investment House boosted its stake in HSIC in the latest quarter, The investment management firm added 1,150 additional shares and now holds a total of 22,090 shares of Henry Schein which is valued at $3,954,331. Henry Schein makes up approx 0.60% of Investment House’s portfolio.Creative Planning boosted its stake in HSIC in the latest quarter, The investment management firm added 1,110 additional shares and now holds a total of 6,526 shares of Henry Schein which is valued at $1,181,924. Henry Schein makes up approx 0.01% of Creative Planning’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in HSIC by selling 22,163 shares or 60.74% in the most recent quarter. The Hedge Fund company now holds 14,327 shares of HSIC which is valued at $2,589,175. Henry Schein makes up approx 0.01% of Bnp Paribas Arbitrage Sa’s portfolio.
Henry Schein closed down -16.15 points or -8.99% at $163.53 with 17,29,466 shares getting traded on Thursday. Post opening the session at $171.1, the shares hit an intraday low of $163.16 and an intraday high of $174 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Henry Schein reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $1.63. The company had revenue of $2872.60 million for the quarter, compared to analysts expectations of $2845.09 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.
Many Wall Street Analysts have commented on Henry Schein. Company shares were Reiterated by Barrington Research on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 188 from a previous price target of $182 .
Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.